Several FOXM1 targets were found upregulated as part of plastic signature in the patient samples (highlighted in bold in Fig. 4A), indicating that FOXM1 is a potential key contributor to the response in ECM stiffness as promoter of cancer progression. The gene discussed is FOXM1; the disease is cancer.